关注妊娠期静脉血栓栓塞症

doi:10.3969/j.issn.1004-583X.2016.04.004

临床荟萃 ›› 2016, Vol. 31 ›› Issue (4): 359-362.doi: 10.3969/j.issn.1004-583X.2016.04.004

关注妊娠期静脉血栓栓塞症

李红蔚, 吴琦

天津市呼吸疾病研究所,天津市海河医院呼吸科,天津 300350

收稿日期:2016-01-15 出版日期:2016-04-05 发布日期:2016-04-18
通讯作者: 吴琦,Email:wq572004@163.com
作者简介:吴琦，教授，主任医师，博士研究生导师，享受国务院特殊津贴专家，天津市海河医院院长，天津市呼吸疾病研究所所长，天津市医学会副会长、呼吸病学分会主任委员。从事肺栓塞、慢性阻塞性肺疾病及呼吸系统传染病临床及基础研究。

Focus on venous thromboembolism during pregnancy

Li Hongwei, Wu Qi

Department of Respiration, Tianjin Haihe Hospital and Tianjin Institute of Respiratory Diseases, Tianjin 300350, China

Received:2016-01-15 Online:2016-04-05 Published:2016-04-18
Contact: Wu Qi, Email: wq572004@163.com

摘要/Abstract

摘要： 肺血栓栓塞症(PTE)和深静脉血栓形成(DVT)合称为静脉血栓栓塞症(VTE)。妊娠期女性由于存在高凝状态、静脉淤滞、血管损伤等特殊的生理变化,VTE发生风险增高。对存在VTE症状或体征的孕产妇,除非存在明确的抗凝禁忌,否则均应尽快行客观检查同时给予抗凝治疗直到完全排除VTE诊断。低分子肝素(LMWH)不通过胎盘,且无哺乳禁忌,是妊娠及产褥期VTE患者抗凝治疗的最佳选择。一旦开始LMWH初始治疗,应该在余下孕程持续使用,直到产后6周,且总疗程不少于3个月。

关键词: 静脉血栓栓塞, 妊娠, 肺栓塞, 静脉血栓形成

Abstract: Venous thromboembolism (VTE) is constituted by pulmonary thromboembolism (PTE) and deep venous thrombosis (DVT). Blood hypercoagulable, along with vascular damage and stasis during pregnancy and puerperium contribute to a high incidence of VTE. In clinically suspected VTE, anticoagulation therapy should be commenced immediately until the diagnosis is excluded by objective testing, unless treatment is strongly contraindicated. Low molecular weight heparin (LMWH) does not pass through the placenta and is safe in breastfeeding, hence will be the best choice for pregnancy and puerperium. Treatment with LMWH should be employed during the remainder of the pregnancy and last for at least 6 weeks postnatally and at least 3 months of treatment will be necessary.

Key words: venous thromboembolism, pregnancy, pulmonary embolism, venous thrombosis

中图分类号:

R619.2

李红蔚, 吴琦. 关注妊娠期静脉血栓栓塞症[J]. 临床荟萃, 2016, 31(4): 359-362.

Li Hongwei, Wu Qi. Focus on venous thromboembolism during pregnancy[J]. Clinical Focus, 2016, 31(4): 359-362.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2016.04.004

https://huicui.hebmu.edu.cn/CN/Y2016/V31/I4/359

参考文献

[1] Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism[J]. Eur Heart J, 2014, 35(43):3033-3069, 3069a-3069k.
[2] Regitz-Zagrosek V, Lundqvist CB, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)[J]. Eur Heart J, 2011, 32(24):3147-3197.
[3] Thromboembolic disease in Pregnancy and the Puerperium: Acute Management[Z]. RCOG Green-top Guideline No. 37b, 2015.[4] James A. Practice bulletin no. 123: thromboembolism in pregnancy[J]. Obstet Gynecol, 2011, 118(3): 718-729.
[5] Bourjeily G, Paidas M, Khalil H, et al. Pulmonary embolism in pregnancy[J]. Lancet,2010,375(9713):500-512.
[6] 许欣, 杜军. 急性肺栓塞症的诊治进展[J]. 临床荟萃, 2013, 28(6):699-702.
[7] Blanco-Molina A, Rota LL, Micco PD, et al. Venous thromboembolism during pregnancy, postpartum or during contraceptive use[J]. Thromb Haemost, 2010, 103(2):306-311.
[8] Leung AN, Bull TM, Jaeschke R, et al. An official American Thoracic Society/Society of Thoracic Radiology clinical practice guideline: evaluation of suspected pulmonary embolism in pregnancy[J]. Am J Respir Crit Care Med, 2011, 184(10):1200-1208.
[9] Gal GL, Kercret G, Yahmed KB, et al. Diagnostic value of single complete compression ultrasonography in pregnant and postpartum women with suspected deep vein thrombosis: prospective study[J]. BMJ, 2012, 344(16):e2635.
[10] Chan WS, Spencer FA, Lee AY, et al. Safety of withholding anticoagulation in pregnant women with suspected deep vein thrombosis following negative serial compression ultrasound and iliac vein imaging[J]. CMAJ, 2013, 185(4):E194-200.
[11] Nguyen CP, Goodman LH. Fetal Risk in Diagnostic Radiology[J]. Semin Ultrasound CT MR, 2012, 33(1):4-10.
[12] Stein PD, Fowler SE, Goodman LR, et al. Multidetector computed tomography for acute pulmonary embolism[J]. N Engl J Med, 2006,354(22): 2317-2327.
[13] Scarsbrook AF, Evans AL, Owen AR, et al. Diagnosis of suspected venous thromboembolic disease in pregnancy[J]. Clin Radiol, 2006, 61(1):1-12.
[14] Knol HM, Schultinge L, Veeger NJ, et al. The risk of postpartum haemorrhage in women using high dose of low-molecular-weight heparins during pregnancy[J]. Thromb Res, 2012, 130(3):334-338.
[15] Greer IA, Catherine NP. Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy[J]. Blood, 2005,106(2):401-407.
[16] Bates SM, Greer IA, Saskia M, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012, 141(Part Ⅱ):e691S-736S.
[17] Christof S, Doreen H, Reinhard M, et al. Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study[J]. Thromb Haemost, 2006, 95(6):949-957.
[18] Tang AW, Greer I. A systematic review on the use of new anticoagulants in pregnancy[J]. Obstetric Medicine, 2013, 6(2):64-71.
[19] Richter C, Jrg Sitzmann, Lang P, et al. Excretion of low molecular weight heparin in human milk[J]. Br J Clin Pharmacol, 2001, 52(6):708-710.
[20] Clark SL, Porter TF, West FG. Coumarin derivatives and breast-feeding[J]. Obstet Gynecol, 2000, 95(6Pt1):938-940.

关注妊娠期静脉血栓栓塞症

Focus on venous thromboembolism during pregnancy

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	刘蕾, 李明武, 万荣. 肺结核合并肺栓塞患者实验室指标的诊断价值[J]. 临床荟萃, 2024, 39(2): 134-139.
[2]	马光宇, 罗慧娟, 王冬菊, 肖小敏. 黄芩苷治疗糖尿病及其并发症的研究进展[J]. 临床荟萃, 2023, 38(8): 757-762.
[3]	冷婉铜, 陶洁. 多发性骨髓瘤患者治疗后发生静脉血栓栓塞的危险因素[J]. 临床荟萃, 2023, 38(4): 340-345.
[4]	唐婷婷, 刘燕, 王春梅, 汪淼芹, 王春燕. 妊娠期糖尿病孕妇自我管理行为与生活质量[J]. 临床荟萃, 2023, 38(12): 1125-1130.
[5]	吴路路, 王瑞亚, 苏林, 冯静. 孕前甘油三酯葡萄糖指数及孕期增重对妊娠期糖尿病患者分娩巨大儿的预测价值[J]. 临床荟萃, 2022, 37(8): 713-716.
[6]	齐琪, 江黎晨, 孙蓉, 胡红琳, 章秋. 妊娠中晚期孕妇血清Gremlin1水平变化及其对妊娠期糖尿病的影响[J]. 临床荟萃, 2022, 37(3): 257-261.
[7]	冯少敏, 韩亚军, 霍琰. 人体成分分析在妊娠期糖尿病中的应用[J]. 临床荟萃, 2022, 37(3): 285-288.
[8]	王娇燕, 章迎春, 任珂明, 马国峰, 应可净. 奥氮平使用合并静脉血栓栓塞症16例临床分析[J]. 临床荟萃, 2022, 37(12): 1108-1113.
[9]	沈瑞, 雷艳花, 贾昊鹍. 145例弥漫性大B细胞淋巴瘤患者静脉血栓栓塞发生率及危险因素分析[J]. 临床荟萃, 2022, 37(1): 43-45.
[10]	王婧, 许芳芳, 刘小转. 妊娠合并主动脉夹层6例回顾性分析[J]. 临床荟萃, 2022, 37(1): 52-56.
[11]	才可新, 郭宏举, 于淑霞, 常李荣. 左旋甲状腺素对妊娠期亚临床甲状腺功能减退症妊娠结局影响的荟萃分析[J]. 临床荟萃, 2021, 36(9): 773-777.
[12]	石瑶, 王虎, 陈敏, 李玉玲. 南充地区妊娠期糖尿病危险因素及妊娠结局分析[J]. 临床荟萃, 2021, 36(9): 795-798.
[13]	王朦朦, 王颖, 陈赵静, 徐贤荣, 杨军, 李红娟. 门冬胰岛素联合维生素D治疗对妊娠期糖尿病患者血糖水平及围产儿并发症影响Meta分析[J]. 临床荟萃, 2021, 36(7): 581-586.
[14]	崔璐, 李静, 刘宇宏. 原发性干燥综合征并发肺栓塞1例并文献复习[J]. 临床荟萃, 2021, 36(4): 361-364.
[15]	杨林红, 钱宝堂, 郝应禄, 李燕萍, 赵静思. 与心脏疾病相关的肺栓塞临床研究现状[J]. 临床荟萃, 2021, 36(3): 285-288.